Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The full-length Thymosin Beta-4 has been investigated in clinical trials by RegeneRx for indications including epidermolysis bullosa, dry eye, and pressure ulcers none of which has resulted in approved use
Research Overview: GHK-Cu, BPC-157, TB-500, and KPV Laboratory investigations reveal synergistic mechanisms for cellular repair, vascular formation, and inflammatory modulationvaluable tools for in vitro research applications
Related Products Also available as individual vials if you need different ratios: BPC-157 5mg and TB-500 10mg
Nausea, dizziness, and headache have been occasionally reported
Sourcing and Research Considerations For either compound, the variables that most affect reproducibility are the same: identity, purity, and handling
US$ 24.75
US$ 29.85
US$ 20.49
US$ 25.96
US$ 21.93
US$ 26.25
US$ 26.74
